NDC 63323-485-01 - Xylocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-485
- Requested NDC
- 63323-485-01
- Package NDCs from labels
- 63323-485-41, 63323-485-26, 63323-485-01, 63323-485-27, 63323-485-03, 63323-485-57
- Manufacturer
- Henry Schein, Inc.
- Effective date
- 2025-11-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Xylocaine 1% (10mg/mL) | Henry Schein, Inc. | 2025-11-07 | HUMAN PRESCRIPTION DRUG LABEL |
| XYLOCAIN (LIDOCAINE HCl ) - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2025-05-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2025-04-22 | HUMAN PRESCRIPTION DRUG LABEL |
| XYLOCAINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-27 | HUMAN PRESCRIPTION DRUG LABEL |
| XYLOCAINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine 1% (10mg/mL) | General Injectables and Vaccines, inc. | 2022-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Fresenius Kabi USA, LLC | Fresenius Kabi Austria | 2021-08-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - Cardinal Health | Cardinal Health | 2020-06-08 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Cardinal Health | Cardinal Health | 2019-09-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine | REMEDYREPACK INC. | 2019-04-30 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine | Physicians Total Care, Inc. | 2012-02-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2011-09-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-485-01 | Xylocaine | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 13 | |
| 63323-485-03 | Xylocaine | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 13 | |
| 63323-485-27 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-485-57 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-485-26 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 7 | |
| 63323-485-41 | Xylocaine | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-485 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 13 | Current NDC, Legacy NDC, 4 package rows | 20210831_ba082c2f-64f4-419d-9c88-74f203316e17.zip |
| 63323-485 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 7 | Current NDC, Legacy NDC, 2 package rows | 20250515_4dd52202-8eef-4136-92dd-ada573b7cf74.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-485-01 | ML - Milliliter | 63323-485 | 55c3520d-d402-4267-87fe-ec239a7384ea | 1 | 2019-12-10 |
| 63323-485-03 | ML - Milliliter | 63323-485 | 8152cfd7-4dd8-49cd-8f86-c8e56a346d48 | 1 | 2019-12-10 |
| 63323-485-26 | ML - Milliliter | 63323-485 | 2b9ff4f4-641e-4bb5-9378-b0f143bdac48 | 1 | 2016-09-02 |
| 63323-485-27 | ML - Milliliter | 63323-485 | 84d0434d-5c06-4795-baaa-4cf67cf1a8e9 | 1 | 2012-07-24 |
| 63323-485-41 | ML - Milliliter | 63323-485 | 7ad5e0f1-7fc8-4e2c-949a-b8a6bf1a6808 | 1 | 2020-07-13 |
| 63323-485-57 | ML - Milliliter | 63323-485 | fcef2f79-20f4-4731-a3c6-7c153a2919bb | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | 3b2dd84e-cee8-4e58-d494-395a65a353a0 | 2026-08-05 | Warnings, Adverse reactions | 1737757 1737343 1010900 1010033 1737636 1737763 1010671 1737562 1737566 1737568 V13007Z41A |
| Lidocaine HCl | LIDOCAINE HCL | Topco Associates LLC | 584e1f35-4d99-9c85-e063-6294a90ab3d0 | 2026-08-05 | Warnings, Adverse reactions | EC2CNF7XFP |
| Lidocaine Plantar Relief Roll-On | LIDOCAINE | Guangzhou Liuquanmiao Import & Export Trade Co., Ltd. | 585ccb4b-3bff-39b9-e063-6294a90a0e18 | 2026-08-05 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | 9c18eaf1-4a0b-4916-70b2-88a827494711 | 2026-08-05 | Warnings, Adverse reactions | 1737761 V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 46404c7b-2ea4-e47b-e063-6294a90a779f | 2026-08-03 | Warnings, Adverse reactions | V13007Z41A |
| Metabatone | ARALIA RACEMOSA, AVENA SATIVA, BERBERIS VULGARIS, CAPSICUM ANNUUM, GINKGO BILOBA, PHYTOLACCA DECANDRA, HYPOTHALAMUS SUIS, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-KETOGLUTARICUM ACIDUM, FEL TAURI, HYALURONIDASE, PANCREAS SUIS, PANCREATINUM, PAPAIN, STOMACH (SUIS), L-ALANINE, L- ARGININE, L-CARNITINE, CYSTEINUM, L-GLUTAMINE, L-HISTIDINE, L-ISOLEUCINE, L-LEUCINE, L-LYSINE, L-METHIONINE, L-ORNITHINE, L-PROLINE, L-SERINE, L-TRYPTOPHAN, L-TYROSINE, L-VALINE, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, IODIUM, | Energique, Inc. | 9510bb76-b717-407d-b9e8-da7743e4cfc8 | 2026-07-31 | Warnings | 451W47IQ8X |
| Bioplasma | SILICON DIOXIDE,POTASSIUM CHLORIDE,SODIUM SULFATE,FERROSOFERRIC PHOSPHATE,MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE,SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE,TRIBASIC CALCIUM PHOSPHATE,POTASSIUM PHOSPHATE, DIBASIC,POTASSIUM SULFATE,SODIUM CHLORIDE,CALCIUM SULFATE ANHYDROUS,CALCIUM FLUORIDE | Hyland's Inc. | dd0a7ed2-d112-4b96-e053-2995a90ac6b6 | 2026-07-30 | Warnings | 451W47IQ8X |
| Hypertonic Saline | SODIUM CHLORIDE | NAVEH PHARMA (1996) LTD | 167c7a9c-1228-4fb2-a89c-d3e148386323 | 2026-07-30 | Warnings | 451W47IQ8X |
| Hypertonic Saline Solution Sodium Chloride | SODIUM CHLORIDE | NAVEH PHARMA (1996) LTD | 750ea4b1-de2b-4299-aaa2-331daf383d0d | 2026-07-30 | Warnings | 451W47IQ8X |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Benco Dental | c5cc87df-df3f-42b8-af84-5f2045d42084 | 2026-07-30 | Warnings, Adverse reactions | 30Q7KI53AK V13007Z41A |
| Aspercreme Lidocaine No-Mess plus Lavender | LIDOCAINE HCL | Chattem, Inc. | 3948a3d2-ce04-4703-8709-211e75c9c38d | 2026-07-29 | Warnings | V13007Z41A |
| Aspercreme Professional Cream | LIDOCAINE HCL 4% | Chattem, Inc. | ef297864-5917-4645-8ec7-f2bc49e037e8 | 2026-07-29 | Warnings | V13007Z41A |
| Xylocaine MPF | LIDOCAINE HYDROCHLORIDE | Sportpharm LLC | 50aa6133-0776-4714-9821-fe8581f635ca | 2026-07-28 | Warnings, Adverse reactions | NDA006488 1737757 1737758 1737761 1737762 EC2CNF7XFP |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Benco Dental | 9419ac39-9b26-4cca-a2d6-167205fede24 | 2026-07-28 | Warnings, Adverse reactions | 30Q7KI53AK V13007Z41A |
| IDkit HP ONE | CITRIC ACID ANHYDROUS AND 13C UREA | Meridian Bioscience Israel Ltd | 8baab7a7-5d20-46ad-9c4a-762992ef6b51 | 2026-07-28 | Warnings, Adverse reactions | 2968PHW8QP |
| LIDOCAINE | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Patterson Dental | 6506755f-c9f7-4286-9ba7-ac5d5745f5e4 | 2026-07-28 | Warnings, Adverse reactions | 30Q7KI53AK V13007Z41A |
| Aspercreme Lidocaine with Rosemary and Mint | LIDOCAINE HYDROCHLORIDE | Chattem, Inc. | 9d40bfea-85d0-4943-83e9-0c16e79a011c | 2026-07-28 | Warnings | V13007Z41A |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Darby Dental Supply, LLC | 27e8fdfb-e923-4f99-aff7-8b9e50228151 | 2026-07-27 | Warnings, Adverse reactions | 30Q7KI53AK V13007Z41A |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Darby Dental Supply, LLC | e5ed4c2a-e320-48cf-a2fd-61d48481c624 | 2026-07-27 | Warnings, Adverse reactions | 30Q7KI53AK V13007Z41A |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Patterson Dental | f074c0dc-7c3f-46fd-a480-b8337a19fe5c | 2026-07-27 | Warnings, Adverse reactions | 30Q7KI53AK V13007Z41A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.